Postprandial cholecystokinin response in patients with chronic pancreatitis in treatment with oral substitutive pancreati enzymes

Digestive Diseases and Sciences

Volumn 43, Issue 3, 1998, Pages 562-566

  Garcés, M Carmen ^a,b   Gómez Cerezo, Jorge ^a   Codoceo, Rosa ^a   Grande, Cristina ^a   Barbado, Javier ^a   Vázquez, Juan José ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cholecystokinin response; Chronic pancreatitis; Oral pancreatic enzymes

Indexed keywords

AMYLASE; CHOLECYSTOKININ; KREON; PANCREATIN; PROTEINASE; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; DRUG EFFECT; DRUG WITHDRAWAL; ENZYME REPLACEMENT; FEMALE; HORMONE RESPONSE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; REFERENCE VALUE; STEATORRHEA; TEST MEAL;

ADULT; CASE-CONTROL STUDIES; CELIAC DISEASE; CHOLECYSTOKININ; CHRONIC DISEASE; FEMALE; FOOD; GASTROINTESTINAL AGENTS; HUMANS; MALE; PANCREATIN; PANCREATITIS; POSTPRANDIAL PERIOD; TIME FACTORS;

EID: 0031969988     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018815225100     Document Type: Article

References (22)

1. Owyang C: Control of exocrine pancreatic secretion. Regul Pept 1:1-7, 1989
2. Mössner J, Stange JH, Ewald MM, Kestel W, Fischbach W: Influence of exogenous application of pancreatic extracts on endogenous pancreatic enzyme secretion. Pancreas 6:637-644, 1991
3. Owyang C, May D, Louie DS: Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enterohepatic reflex. Gastroenterology 91:637-643, 1986
4. Dlugosz J, Folsch UR, Czajkowski A, Gabryelewicz A: Feedback regulation of stimulated pancreatic enzyme secretion during intraduodenal perfusion of trypsin in man. Eur J Clin Invest 18:267-272, 1988
5. Adler G, Reinshagen M, Koop I, et al: Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion. Gastroenterology 96:1158-1164, 1989
6. Hotz J, Ho SB, Go VLW, DiMagno EP: Short-term inhibition of duodenal tryptic activity does not affect human pancreatic, biliary or gastric function. J Lab Clin Med 101:488-495, 1983
7. Layer P, Jansen JBMJ, Charian L, Lamers CBHW, Goebell H: Feedback regulation of human pancreatic secretion: Effect of protease inhibition on duodenal delivery and small intestine transit of pancreatic enzymes. Gastroenterology 98:1311-1319, 1990
8. Mössner J, Wresky HP, Kestel W, Zeeh J, Regner U, Fischbach W: Influence of treatment with pancreatic extracts on pancreatic enzyme secretion. Gut 30:1143-1149, 1989
9. Dominguez-Muñoz JE, Birkelbach U, Sauerbruch T, Nuber R, Malfertheiner P: Estudio de las enzimas pancreáticas exógenas sobre la función digestiva en sujetos sanos: Estudio comparative de dos preparaciones galénicas. Rev Esp Enf Dig 10:728-729, 1996 (Abstract)
10. Schafmeyer A, Becher HD, Werner M, Flsch UR, Creutzfeldt W: Plasma cholecystokinin levels in patients with chronic pancreatitis. Digestion 32:136-139, 1985
11. Fumakoshi A, Nakano J, Shinzaki H, Tateishi K, Hamaoka T, Ibayashi H: High plasma cholecystokinin levels in patients with chronic pancreatitis having pain. Am J Gastroentcrol 81:1174-1178, 1986
12. Cantor P, Petronijevic L, Worning H: Plasma cholecystokinin concentrations in patients with advanced chronic pancreatitis. Pancreas 1:488-493, 1986
13. Bozkurt T, Adler G, Koop I, Koop H, Türmer W, Arnold R: Plasma CCK levels in patients with pancreatic insufficiency. Dig Dis Sci 33:276-281, 1988
14. Glasbrenner B, Malfertheiner P, Pieramico O, Klatt S, Riepl R, Friess H, Ditschuneit H: Gallbladder dynamics in chronic pancreatitis. Relationship to exocrine pancreatic function, CCK and PP release. Dig Dis Sci 38:482-489, 1993
15. Jansen JBMJ, Jebbing MCW, Lamers CBHW: Effect of pancreatic enzymes on postprandial plasma cholecystokinin secretion. Digestion 38:26-27, 1987 (abstract)
16. Campbell D, Jadunandan I, Curington C, Liddle R, Solomon T, Toskes P: Alcoholic and idiopathic patients with painful chronic pancreatitis do not experience suppression of CCK levels or pain relief following treatment enteric-coated pancreatin. Gastroenterology 102:A259, 1992 (abstract)
17. Gómez-Cerezo J, Codoceo R, Fernández-Calle P, Molina F, Tenias JM, Vázquez JJ: Basal and postprandial cholecystokinin values in chronic pancreatitis with and without abdominal pain. Digestion 48:134-140, 1991
18. Reseland JE, Holan H, Jenssen T, Jacobsen MB, Hanssen E: Inhibitor-stimulated non-parallel pancreatic secretion in man: Hormonal and neural regulation. Scand J Gastroenterol 30:72-80, 1995
19. Reseland JE, Holan H, Jacobsen MB, Jenssen T, Hanssen E: Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion. J Nutr 126:634-642, 1996
20. Nealon WH, Townsend CN, Shabot M, Beauchamp RD, Boyd G, Thompsom JC: Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitis. Ann Surg 204:430-436, 1986
21. Nakamura T, Takebe K, Kudoh K, Ishii M, Imamura K, Kikuchi H, Kasai F, Tandoh Y, Yamada N, Arai Y, et al: No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency. Int J Pancreatol 17:29-35, 1995
22. Domschke S, Bloom SR, Adrian TE, Lux G, Domschke W: Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin). Hepatogastroenterology 35:229-237, 1988